...
首页> 外文期刊>Lasers in surgery and medicine >Long-term results in the treatment of childhood hemangioma with the flashlamp-pumped pulsed dye laser: an evaluation of 617 cases.
【24h】

Long-term results in the treatment of childhood hemangioma with the flashlamp-pumped pulsed dye laser: an evaluation of 617 cases.

机译:治疗儿童的长期结果血管瘤flashlamp-pumped脉冲染料激光:一个评估617例。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND AND OBJECTIVE: Presenting the long-term results of flashlamp-pumped pulsed dye laser treatment in 617 hemangiomas to evaluate this treatment modality. STUDY DESIGN/MATERIALS AND METHODS: In 548 children, 692 hemangiomas were treated with the flashlamp-pumped pulsed dye laser (FPDL) SPTL 1B (Candela Corporation, Wayland, MA). The objective of treatment was the inhibition of further growth or the induction of regression. The treatment results were documented by the treating physician as well as by means of a questionnaire delivered to the parents. A total of 617 treatment results could be evaluated. RESULTS: After 1--12 treatments (mean, 2.5), we could achieve our treatment objective to stop the further growth of the lesion in 96.6% of all hemangiomas. In 13.8%, the treatment resulted in a complete remission, a significant regression was seen in 14.9%, and 67.9% of the treated lesions showed a discontinuation of growth. The percentage of complete remission was especially high in small superficial (42.6%) and superficial (19%) hemangiomas. CONCLUSION: In the vast majority of the hemangiomas, it was possible to stop further progression or induce regression by FPDL treatment. Total regression could be achieved in nearly half of the small superficial hemangiomas. Because the treatment is fast, effective, and nearly without side effects, we recommend early laser treatment especially in superficial and small childhood hemangiomas. Copyright 2001 Wiley-Liss, Inc.
机译:背景和目的:长期flashlamp-pumped脉冲染料激光器的结果617年治疗肝血管瘤评估治疗方法。方法:692年548名儿童,肝血管瘤对待flashlamp-pumped脉冲染料激光(FPDL) SPTL 1 b(烛光公司,韦兰,MA)。进一步增长的抑制或诱导回归。治疗的医生以及通过一份调查问卷给父母。617可以评估治疗结果。结果:1——12治疗后(意思是,2.5),我们可以实现我们的治疗目标停止在96.6%的病变的进一步增长肝血管瘤。一个完整的缓解,一个重要的回归在14.9%,和67.9%的治疗病变显示停止增长。完全缓解尤其的百分比在小的表面(42.6%)和肤浅的(19%)的血管瘤。大多数血管瘤,是可能的停止进一步的恶化或诱发回归FPDL治疗。实现在将近一半的小肤浅肝血管瘤。有效,几乎没有副作用,我们特别是在推荐早期激光治疗表面和小儿童血管瘤。版权2001 Wiley-Liss公司。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号